Ultra-wide-field Fluorescein Angiography in Patients With Macular Edema Secondary to Retinal Vein Occlusion

NCT04140448 · clinicaltrials.gov ↗

UNKNOWN

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Retinal Vein Occlusion
Macular Edema

Interventions

DRUG: Ranibizumab 0.5 MG/0.05 ML Intraocular Solution [LUCENTIS]
DEVICE: Ultra-wide Fluorescein Angiography

Sponsor

Renmin Hospital of Wuhan University